TY - JOUR
T1 - Genome-Wide Profiling of Acquired Uniparental Disomy Reveals Prognostic Factors in Head and Neck Squamous Cell Carcinoma
AU - Tuna, Musaffe
AU - Liu, Wenbin
AU - Amos, Christopher I.
AU - Mills, Gordon B.
N1 - Funding Information:
This study supported by The University of Texas MD Anderson's Cancer Center Support Grant (CCSG) NIH/NCI_P30CA016672.
Funding Information:
The authors thank Erica A. Goodoff of Department of Scientific Publication (The University of Texas, MD Anderson Cancer Center) for editing the manuscript. This study supported by The University of Texas MD Anderson's Cancer Center Support Grant (CCSG) NIH/NCI_P30CA016672. The authors declare no potential conflicts of interest. MT conceived and coordinated the study. MT and GBM designed the study. MT developed the methodology. MT, WL, CIA,GBM analyzed and interpreted the data; MT draft the manuscript; MT, WL, CIA and GBM critically discussed the data and revised the manuscript. All authors read and approved final manuscript.
Publisher Copyright:
© 2019 The Authors
PY - 2019/11
Y1 - 2019/11
N2 - Acquired uniparental disomy (aUPD) leads to homozygosity facilitating identification of monoallelically expressed genes. We analyzed single-nucleotide polymorphism array-based genotyping data of 448 head and neck squamous cell carcinoma (HNSCC) samples from The Cancer Genome Atlas to determine the frequency and distribution of aUPD regions and their association with survival, as well as to gain a better understanding of their influence on the tumor genome. We used expression data from the same dataset to identify differentially expressed genes between groups with and without aUPD. Univariate and multivariable Cox proportional hazards models were performed for survival analysis. We found that 82.14% of HNSCC samples carried aUPD; the most common regions were in chromosome 17p (31.25%), 9p (30.13%), and 9q (27.46%). In univariate analysis, five independent aUPD regions at chromosome 9p, two regions at chromosome 9q, and the CDKN2A region were associated with poor overall survival in all groups, including training and test sets and human papillomavirus (HPV)-negative samples. Forty-three genes in areas of aUPD including PD-L1 and CDKN2A were differentially expressed in samples with aUPD compared to samples without aUPD. In multivariable analysis, aUPD at the CDKN2A region was a significant predictor of overall survival in the whole cohort and in patients with HPV-negative HNSCC. aUPD at specific regions in the genome influences clinical outcomes of HNSCC and may be beneficial for selection of personalized therapy to prolong survival in patients with this disease.
AB - Acquired uniparental disomy (aUPD) leads to homozygosity facilitating identification of monoallelically expressed genes. We analyzed single-nucleotide polymorphism array-based genotyping data of 448 head and neck squamous cell carcinoma (HNSCC) samples from The Cancer Genome Atlas to determine the frequency and distribution of aUPD regions and their association with survival, as well as to gain a better understanding of their influence on the tumor genome. We used expression data from the same dataset to identify differentially expressed genes between groups with and without aUPD. Univariate and multivariable Cox proportional hazards models were performed for survival analysis. We found that 82.14% of HNSCC samples carried aUPD; the most common regions were in chromosome 17p (31.25%), 9p (30.13%), and 9q (27.46%). In univariate analysis, five independent aUPD regions at chromosome 9p, two regions at chromosome 9q, and the CDKN2A region were associated with poor overall survival in all groups, including training and test sets and human papillomavirus (HPV)-negative samples. Forty-three genes in areas of aUPD including PD-L1 and CDKN2A were differentially expressed in samples with aUPD compared to samples without aUPD. In multivariable analysis, aUPD at the CDKN2A region was a significant predictor of overall survival in the whole cohort and in patients with HPV-negative HNSCC. aUPD at specific regions in the genome influences clinical outcomes of HNSCC and may be beneficial for selection of personalized therapy to prolong survival in patients with this disease.
UR - http://www.scopus.com/inward/record.url?scp=85074895718&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074895718&partnerID=8YFLogxK
U2 - 10.1016/j.neo.2019.08.008
DO - 10.1016/j.neo.2019.08.008
M3 - Article
C2 - 31734631
AN - SCOPUS:85074895718
SN - 1522-8002
VL - 21
SP - 1102
EP - 1109
JO - Neoplasia (United States)
JF - Neoplasia (United States)
IS - 11
ER -